Bladder cancer, Kidney cancer
Open
Phase 2
This trial is comparing 3 with the standard 6 cycles for urinary tract cancer that has spread.
It is for people who:
have urothelial cancer that has grown into nearby tissues or has spread to another part of the body
are going to have an called avelumab after chemotherapy
Recruitment start: 12 December 2021
Recruitment end: 30 April 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Thomas Powles
Merck
Queen Mary University of London
Last reviewed: 7 July 2025
CRUK internal database number: 18104